Venous thromboembolism (VTE) prophylaxis for surgical patients
cannot be overemphasized. The Joint Commission, the American College
of Surgeons, the American College of Chest Physicians, the Agency
for Healthcare Research and Quality, and others advocate risk-appropriate
prophylaxis for all surgical patients. Despite strong evidence supporting
its efficacy, VTE prophylaxis is frequently underutilized, with reported
rates of 32% to 59%.1,2 Although VTE has been labeled a “never event” by some
organizations, it is clear that many hospital-acquired events are
not preventable.3,4 A
newly suggested definition of preventable harm linking the process
of VTE prophylaxis to outcomes3 has
been adopted as a Clinical Quality Measure by the Centers for Medicare
and Medicaid Services in their “meaningful use” incentive
program. We sought to link process and outcome data from disparate
sources in order to determine the proportions of surgical patients
prescribed risk-appropriate VTE prophylaxis who developed potentially
Figure. The percentage of patients
with postoperative venous thromboembolism (VTE), deep vein thrombosis
(DVT), and pulmonary embolism (PE) who were prescribed risk-appropriate
VTE prophylaxis compared with those who were not. The vast majority
of VTE events occurred in patients prescribed risk-appropriate prophylaxis.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.